Company page

Rallybio Corporation

Rallybio Corporation is a public company traded under the ticker RLYB in the American market. With a market capitalization of approximately $84.6 million, Rallybio focuses on developing innovative therapies for rare diseases. The company is committed to advancing its pipeline and addressing unmet medical needs.